All Updates

All Updates

icon
Filter
Funding
Genialis raises USD 13 million in Series A funding
Precision Medicine
Mar 29, 2023
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Precision Medicine

Precision Medicine

Mar 29, 2023

Genialis raises USD 13 million in Series A funding

Funding

  • Genialis, a computational bioinformatics company, has raised more than USD 13 million in a Series A funding round led by Taiwania Capital and Debiopharm Innovation Fund, with participation from P5 Health Ventures and existing investors. This brings total funds raised to USD 15.5 million. 

  • The funds will be used to expand the company’s ResponderID platform, develop next-generation patient classifiers using machine learning and high-throughput omics data, and build out clinically validated biomarker models to provide pinpoint diagnoses for cancer patients. The funds will also be used to grow its teams in the US and Slovenia.

  • Genialis is a computational precision medicine company that uses its machine-learning-driven ResponderID platform to provide biomarkers for disease modeling, drug development, and clinical care. The company has collaborated with biopharma to analyze clinical trial data and inform future trial designs for investigational drugs, and supports the commercialization of next-gen biomarker assays with leading diagnostic firms. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.